Search Results

There are 13622 results for: content related to: Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel

  1. You have free access to this content
    Clopidogrel Resistance: Identifying and Overcoming a Barrier to Effective Antiplatelet Treatment

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: e100–e111, Shinichiro Uchiyama

    Article first published online : 31 JUL 2011, DOI: 10.1111/j.1755-5922.2010.00202.x

  2. You have free access to this content
    Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 10, October 2011, Pages: 1892–1901, A. M. HARMSZE, J. W. VAN WERKUM, P. C. SOUVEREIN, N. J. BREET, H. J. BOUMAN, C. M. HACKENG, H. J. T. RUVEN, J. M. TEN BERG, O. H. KLUNGEL, A. DE BOER and V. H. M. DENEER

    Article first published online : 29 SEP 2011, DOI: 10.1111/j.1538-7836.2011.04483.x

  3. You have free access to this content
    Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 8, August 2010, Pages: 1820–1827, H. M. JUDGE, S. B. PATIL, R. J. BUCKLAND, J. A. JAKUBOWSKI and R. F. STOREY

    Article first published online : 21 MAY 2010, DOI: 10.1111/j.1538-7836.2010.03925.x

  4. You have free access to this content
    Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 9, September 2007, Pages: 1839–1847, R. PANICCIA, E. ANTONUCCI, A. M. GORI, R. MARCUCCI, C. GIGLIOLI, D. ANTONIUCCI, G. F. GENSINI, R. ABBATE and D. PRISCO

    Article first published online : 9 JUN 2007, DOI: 10.1111/j.1538-7836.2007.02656.x

  5. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Article first published online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  6. You have free access to this content
    Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

    Journal of Bone and Mineral Research

    Volume 27, Issue 11, November 2012, Pages: 2373–2386, Susanne Syberg, Andrea Brandao-Burch, Jessal J Patel, Mark Hajjawi, Timothy R Arnett, Peter Schwarz, Niklas R Jorgensen and Isabel R Orriss

    Article first published online : 16 OCT 2012, DOI: 10.1002/jbmr.1690

  7. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Article first published online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  8. You have full text access to this OnlineOpen article
    Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

    Cardiovascular Therapeutics

    Volume 27, Issue 4, Winter 2009, Pages: 259–274, Steen Husted and J.J.J. Van Giezen

    Article first published online : 10 JUL 2009, DOI: 10.1111/j.1755-5922.2009.00096.x

  9. Personalizing Antiplatelet Therapy With Clopidogrel

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 476–485, D Trenk, O Zolk, M F Fromm, F-J Neumann and W Hochholzer

    Article first published online : 5 SEP 2012, DOI: 10.1038/clpt.2012.133

  10. You have free access to this content
    Clopidogrel “Resistance”: Where are We Now?

    Cardiovascular Therapeutics

    Volume 31, Issue 1, February 2013, Pages: 3–11, Zeshan Qureshi and Alex R. Hobson

    Article first published online : 3 AUG 2011, DOI: 10.1111/j.1755-5922.2011.00296.x

  11. Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans

    The Journal of Clinical Pharmacology

    Volume 50, Issue 2, February 2010, Pages: 126–142, Dr Nagy A. Farid, Dr Atsushi Kurihara and Dr Steven A. Wrighton

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009343005

  12. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Article first published online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  13. You have free access to this content
    A case–control study on platelet reactivity in patients with coronary stent thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 5, May 2011, Pages: 909–916, H. J. BOUMAN, J. W. VAN WERKUM, N. J. BREET, H. TEN CATE, C. M. HACKENG and J. M. TEN BERG

    Article first published online : 6 MAY 2011, DOI: 10.1111/j.1538-7836.2011.04255.x

  14. Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 6, June 2015, Pages: 920–930, V. Khanna, R. Mikael, K. Thayalasamy, N. Sambu, B. D. Dimitrov, N. Englyst, A. L. Calver, S. Corbett, H. Gray, I. A. Simpson, J. R. Wilkinson and N. Curzen

    Article first published online : 23 APR 2015, DOI: 10.1111/jth.12909

  15. Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 9, September 2009, Pages: 1089–1102, Dr. Paul P. Dobesh

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.9.1089

  16. Clopidogrel Use in End-Stage Kidney Disease

    Seminars in Dialysis

    Volume 28, Issue 3, May–June 2015, Pages: 276–281, Bassem Y. Tanios, Houssam S. Itani and Deborah L. Zimmerman

    Article first published online : 5 DEC 2014, DOI: 10.1111/sdi.12338

  17. You have free access to this content
    Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 697–706, Terry K. W. Ma, Yat-Yin Lam, Victoria P. Tan and Bryan P. Yan

    Article first published online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.03949.x

  18. Differential Impact of Selective Serotonin Reuptake Inhibitors on Platelet Response to Clopidogrel: A Randomized, Double-Blind, Crossover Trial

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 2, February 2015, Pages: 140–147, Bruria Hirsh/Rokach, Galia Spectre, Ela Shai, Amit Lotan, Amit Ritter, Fadiea Al-Aieshy, Rickard E. Malmström, David Varon and Ronny Alcalai

    Article first published online : 17 FEB 2015, DOI: 10.1002/phar.1542

  19. Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 4, April 2012, Pages: 541–552, Mohamed Ali Lassoued, Souad Sfar, Abderrahman Bouraoui and Fathia Khemiss

    Article first published online : 29 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01434.x

  20. Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue 6, June 2015, Pages: 650–658, EK Tarkiainen, MT Holmberg, A Tornio, M Neuvonen, PJ Neuvonen, JT Backman and M Niemi

    Article first published online : 9 MAY 2015, DOI: 10.1002/cpt.101